- Home
- LDP vs PACB Comparison
LDP vs PACB Comparison
Compare LDP & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LDP | PACB |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 615.9M | 521.8M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | LDP | PACB |
|---|---|---|
| Price | $21.21 | $1.49 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $1.67 |
| AVG Volume (30 Days) | 43.4K | ★ 6.0M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 7.91% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | N/A | $11.32 |
| Revenue Next Year | N/A | $12.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $19.35 | $1.09 |
| 52 Week High | $22.05 | $2.73 |
Technical Indicators
Market Signals| Indicator | LDP | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 63.68 | 49.02 |
| Support Level | $21.10 | $1.31 |
| Resistance Level | $21.50 | $1.79 |
| Average True Range (ATR) | 0.18 | 0.13 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 85.19 | 36.21 |
Price Performance
Historical ComparisonAbout LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.